Since [18F]OP-801-PET has recently been translated for clinical use, it holds high potential for monitoring of immunomodulatory therapies in MS patients. ![Figure][1] ![Figure][1] [1]: pendinRenesmee KuoMackenzie CarlsonNoeen MalikSamantha Reyes...
Results [18F]OP-801 was produced with >95% radiochemical purity, 12–52 μCi/μg specific activity, and 4.3±1.5% decay-corrected yield. Ex vivo metabolite analysis of plasma samples (n=4) demonstrated high stability in mice (97±3% intact tracer >120 min post-...